N6-methyladenosine-associated prognostic pseudogenes contribute to predicting immunotherapy benefits and therapeutic agents in head and neck squamous cell carcinoma.
- Resource Type
- Article
- Source
- Theranostics; 2022, Vol. 12 Issue 17, p7267-7288, 22p
- Subject
- Language
- ISSN
- 18387640